FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064537 [Registered on: 20/03/2024] Trial Registered Prospectively
Last Modified On: 20/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To study the relationship of salivary hs-CRP with the regular cardiovascular risk factors and HbA1c in prediabetic patients. 
Scientific Title of Study   Correlation of salivary hs-CRP with conventional cardiovascular risk markers and HbA1c in prediabetic subjects.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gautam Bedi 
Designation  Junior Resident  
Affiliation  Datta Meghe Institute of Higher education and research  
Address  Department of General Medicine, Datta Meghe Institute of Higher Education and Research, JNMC, Sawangi, Wardha, Maharashtra

Wardha
MAHARASHTRA
442001
India 
Phone  9672634064  
Fax    
Email  sarang141@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sourya Acharya 
Designation  Professor  
Affiliation  Datta Meghe Institute of Higher education and research  
Address  Department of General Medicine, Datta Meghe Institute of Higher Education and Research, JNMC, Sawangi, Wardha, Maharashtra

Wardha
MAHARASHTRA
442001
India 
Phone  9511840372  
Fax    
Email  souryaacharya74@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gautam Bedi 
Designation  Junior Resident  
Affiliation  Datta Meghe Institute of Higher education and research  
Address  Department of General Medicine, Datta Meghe Institute of Higher Education and Research, JNMC, Sawangi, Wardha, Maharashtra

Wardha
MAHARASHTRA
442001
India 
Phone  9672634064  
Fax    
Email  sarang141@gmail.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute Of Higher Education and Research, Sawangi (Meghe), Wardha-442001, Maharashtra, India. 
 
Primary Sponsor  
Name  Dr Gautam Bedi 
Address  Department of General Medicine, Datta Meghe Institute of Higher Education and Research, JNMC, Sawangi, Wardha, Maharashtra  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gautam Bedi  Datta Meghe Institute Of Higher Education and Research  Department of Medicine, JNMC, Datta Meghe Institute Of Higher Education and Research, Sawangi (Meghe), Wardha, Maharashtra, India.
Wardha
MAHARASHTRA 
9672634064

sarang141@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Datta Meghe Institute Of Higher Education And Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All the consenting patients of 45 years and above with risk factors, attending medicine OPD or getting admitted in medicine ward of DMIHER Wardha. 
 
ExclusionCriteria 
Details  1. Patients refusing informed consent
2. Patients who have previous diagnosis of diabetes mellitus.
3. Patients suffering from iron deficiency and sickle cell anemia.
4. Patients receiving HIV treatment.
5. Pregnancy
6. Postpartum patients
7. Patients on hemodialysis and chronic kidney disease
8. Patients with chronic liver disease
9. Patients who have received recent blood transfusion or are on erythropoietin therapy.
10. Patients who have undergone salivary gland surgery.
11. Patients who are smokers and alcoholics
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
salivary HsCRP in prediabetic subjects  on day 1 morning between 9am-11am. 
 
Secondary Outcome  
Outcome  TimePoints 
Total Cholesterol, HDL, LDL, VLDL, Triglycerides, HbA1C, Body Mass Index, Waist Circumference, Waist Hip Ratio, Neck Circumference in prediabetic subjects.  on day 1 After 8 hours of overnight fast 
 
Target Sample Size   Total Sample Size="95"
Sample Size from India="95" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   IT IS A CROSS SECTIONAL OBSERVATIONAL STUDY IN WHICH CORRELATION OF SALIVARY HS-CRP WILL BE DONE WITH CONVENTIONAL CARDIO VASCULAR RISK MARKERS AND HBA1C IN PRE DIABETIC SUBJECTS WITH THE PURPOSE TO SAVE MANY PREDIABETICS FROM CONVERTING INTO OVERT DIABETES AND ALSO DECREASE THE PREDISPOSITON TO CARDIAC DISEASE. THIS WILL ALSO HELP TO REDUCE THE IMMENSE ECONOMIC BURDEN ON THE SOCIETY. 
Close